Holen Sie sich die Stockscreener-App
4.89
0.40%
-0.06
Schlusskurs vom Vortag:
$4.95
Offen:
$4.93
24-Stunden-Volumen:
13,393
Relative Volume:
0.23
Marktkapitalisierung:
$212.12M
Einnahmen:
$4.71M
Nettoeinkommen (Verlust:
$-46.77M
KGV:
-2.9121
EPS:
-1.6792
Netto-Cashflow:
$-60.34M
1W Leistung:
+4.67%
1M Leistung:
+0.26%
6M Leistung:
-36.35%
1J Leistung:
-34.62%
1-Tages-Spanne:
$4.8743
$4.99
1-Wochen-Bereich:
$4.60
$5.00
52-Wochen-Spanne:
$4.345
$11.87
Nyxoah Sa Stock (NYXH) Company Profile
Vergleichen Sie NYXH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
4.93 | 212.98M | 4.71M | -46.77M | -60.34M | -1.6792 |
|
ISRG
Intuitive Surgical Inc
|
560.79 | 200.96B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
189.15 | 54.09B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.97 | 38.74B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
246.74 | 36.50B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
266.88 | 19.36B | 2.96B | 487.70M | 344.00M | 6.6758 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-31 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2022-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-12-21 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-07-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Nyxoah Sa Aktie (NYXH) Neueste Nachrichten
Nyxoah announces shareholding changes as Robert Taub surpasses 10% threshold - MSN
Nyxoah Announces Shareholding Changes as Robert Taub Surpasses 10% Threshold - TipRanks
How Nyxoah SA (5YI) stock compares with tech leadersWeekly Stock Analysis & Community Verified Trade Signals - Newser
Will Nyxoah SA stock outperform international peersIPO Watch & Accurate Technical Buy Alerts - Newser
Is Nyxoah SA stock a buy for dividend growthJuly 2025 Levels & Risk Controlled Daily Plans - Newser
Will Nyxoah SA (5YI) stock remain on Wall Street radar2025 Institutional Moves & Reliable Breakout Forecasts - Newser
Nyxoah (NYXH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Publication relating to transparency notifications - marketscreener.com
Can Nyxoah SA (5YI) stock sustain institutional flowsJuly 2025 Intraday Action & Daily Chart Pattern Signals - Newser
What MACD trends signal for Nyxoah SA (5YI) stock2025 Dividend Review & Verified Entry Point Signals - Newser
Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System - sharewise.com
Nyxoah’s Genio Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule - Sleep Review
Why Nyxoah SA stock is recommended by analystsTrade Entry Report & AI Driven Stock Price Forecasts - moha.gov.vn
How Nyxoah SA stock performs in high volatility marketsRecession Risk & Trade Opportunity Analysis Reports - moha.gov.vn
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewswire
Nyxoah receives Medicare reimbursement increases for Genio - MSN
Nyxoah (NASDAQ: NYXH) schedules webcast fireside chat at Piper Sandler healthcare conference - Stock Titan
Nyxoah SA Stock Rises Pre-Market After CMS Raises Reimbursement For Sleep Disorder Therapy - MSN
Nyxoah S.A. (NASDAQ:NYXH) Q3 2025 Earnings Call Transcript - MSN
Nyxoah’s Genio therapy gets significant 2026 Medicare reimbursement increases under final CMS rule - MSN
01 Communique (TSXV: ONE) teams with Turnium to expand IronCAP X quantum-safe email - Stock Titan
Nyxoah SA (NYXH) Q3 2025 Earnings Call Highlights: Strong US Launch and Strategic Expansion ... By GuruFocus - Investing.com Canada
Will Supply Chain Issues Impact Indian Toners Developers Limiteds PerformanceExit Strategy Tips & High Profit Investment Ideas - earlytimes.in
Will Nyxoah SA (5YI) stock extend growth storyCPI Data & Accurate Technical Buy Alerts - newser.com
Can Nyxoah SA stock sustain free cash flow growth2025 Key Lessons & Free Real-Time Market Sentiment Alerts - newser.com
Why Nyxoah SA (5YI) stock attracts wealthy investorsIndex Update & Consistent Growth Equity Picks - newser.com
Nyxoah (NASDAQ: NYXH) Reports 43,026,460 Voting Rights and Share Capital Update - Stock Titan
Why Nyxoah SA stock is seen as undervaluedJuly 2025 Decliners & Low Drawdown Investment Strategies - newser.com
Can Nyxoah SA stock sustain market leadershipJuly 2025 Market Mood & AI Forecasted Stock Moves - newser.com
Information on the total number of voting rights and shares - GlobeNewswire
Should I buy Nyxoah SA (5YI) stock before earnings seasonWeekly Risk Report & Daily Chart Pattern Signals - newser.com
How Nyxoah SA (5YI) stock trades under stagflation2025 EndofYear Setup & Safe Capital Investment Plans - newser.com
How Nyxoah SA (5YI) stock compares with market leaders2025 Support & Resistance & Momentum Based Trading Signals - newser.com
How high can Nyxoah SA stock go2025 Dividend Review & Weekly Setup with ROI Potential - newser.com
Heatmap analysis for Nyxoah SA and competitorsJuly 2025 Breakouts & Detailed Earnings Play Strategies - newser.com
Latham DQ'd From Sleep Apnea Device Co.'s Patent Fight - Law360
How Nyxoah SA (5YI) stock trades pre earningsJuly 2025 Final Week & Verified Momentum Stock Watchlist - newser.com
Can Nyxoah SA (5YI) stock double in coming yearsMarket Rally & Weekly Top Stock Performers List - newser.com
Latham & Watkins Disqualified in Inspire IP Suit Against Nyxoah - Bloomberg Law News
Finanzdaten der Nyxoah Sa-Aktie (NYXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
2.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):